Atypical autism

Atypical autism, also known as pervasive developmental disorder not otherwise specified (PDD-NOS) in older classification systems, is a neurodevelopmental condition classified under the autism spectrum. It is coded as F84.1 in ICD-10 and is listed in Orphanet under code 199627. Atypical autism differs from classic autism (Kanner-type) in that it may present with a later age of onset (after age 3), may not fulfill all three diagnostic criteria domains (impaired social interaction, impaired communication, and restricted/repetitive behaviors), or may occur in individuals with severe intellectual disability where behavioral assessment is complicated. The condition primarily affects the central nervous system, impacting brain development and function. Key clinical features include difficulties in social interaction, challenges with verbal and nonverbal communication, and in some cases restricted interests or repetitive behaviors — though not all of these domains need to be fully affected for diagnosis. Individuals may also present with varying degrees of intellectual disability, language delay, and difficulties with adaptive functioning. The severity and combination of symptoms are highly variable between individuals, which is a hallmark of this diagnosis. There is currently no cure for atypical autism. Management is multidisciplinary and individualized, typically involving behavioral interventions (such as applied behavior analysis), speech and language therapy, occupational therapy, social skills training, and special educational support. Pharmacological treatment may be used to address specific co-occurring symptoms such as anxiety, irritability, attention difficulties, or sleep disturbances, but medications do not treat the core features of the condition. Early intervention is associated with improved developmental outcomes. Genetic counseling may be offered to families, as the etiology is believed to be multifactorial, involving complex interactions between genetic susceptibility and environmental factors.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Atypical autism